Decursin and Decursinol Angelate: New Compounds Against Breast Cancer
Author Information
Author(s): Jiang Cheng, Guo Junming, Wang Zhe, Xiao Bingxiu, Lee Hyo-Jung, Lee Eun-Ok, Kim Sung-Hoon, Lu Junxuan
Primary Institution: The Hormel Institute, University of Minnesota
Hypothesis
Do decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth of breast cancer cells?
Conclusion
Decursin and decursinol angelate effectively inhibit the growth of breast cancer cells by targeting estrogen receptor signaling.
Supporting Evidence
- Decursin and DA caused G1 arrest and apoptosis in MCF-7 cells.
- These compounds decreased ERĪ± levels in MCF-7 cells.
- Decursin and DA induced cell-cycle arrests in MDA MB-231 cells.
- Decursinol did not exhibit similar effects at comparable concentrations.
Takeaway
Decursin and its cousin, decursinol angelate, can help stop breast cancer cells from growing by blocking the effects of estrogen.
Methodology
The study involved treating MCF-7 and MDA MB-231 breast cancer cells with decursin and decursinol angelate, followed by assessments of cell growth, apoptosis, and estrogen receptor expression.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website